AbbVie Inc. (TSX:ABBV)
39.62
+0.30 (0.76%)
Oct 16, 2026, 3:56 PM EST
AbbVie Employees
AbbVie had 57,000 employees as of December 31, 2025. The number of employees increased by 2,000 or 3.64% compared to the previous year.
Employees
57,000
Change
2,000
Growth
3.64%
Revenue / Employee
1.60M CAD
Profits / Employee
156.21K CAD
Market Cap
713.44B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57,000 | 2,000 | 3.64% |
| Sep 30, 2025 | 55,000 | 5,000 | 10.00% |
| Jun 30, 2025 | 55,000 | 5,000 | 10.00% |
| Mar 31, 2025 | 55,000 | 5,000 | 10.00% |
| Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
| Sep 30, 2024 | 50,000 | 0 | - |
| Jun 30, 2024 | 50,000 | 0 | - |
| Mar 31, 2024 | 50,000 | 0 | - |
| Dec 31, 2023 | 50,000 | 0 | - |
| Sep 30, 2023 | 50,000 | 0 | - |
| Jun 30, 2023 | 50,000 | 0 | - |
| Mar 31, 2023 | 50,000 | 0 | - |
| Dec 31, 2022 | 50,000 | 0 | - |
| Sep 30, 2022 | 50,000 | 0 | - |
| Jun 30, 2022 | 50,000 | 2,000 | 4.17% |
| Mar 31, 2022 | 50,000 | 2,000 | 4.17% |
| Dec 31, 2021 | 50,000 | 3,000 | 6.38% |
| Sep 30, 2021 | 50,000 | 3,000 | 6.38% |
| Mar 31, 2021 | 48,000 | 18,000 | 60.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,500 |
| Sienna Senior Living | 15,000 |
| Apotex Health | 6,000 |
| Curaleaf Holdings | 5,554 |
| Green Thumb Industries | 4,900 |
| WELL Health Technologies | 1,507 |
| Knight Therapeutics | 830 |
| Vireo Growth | 612 |
AbbVie News
- 1 day ago - SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026 - PRNewsWire
- 2 days ago - Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets - Market Watch
- 5 days ago - Biotech's Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticism - ETF Trends
- 6 days ago - AbbVie announces presentation of 22 scientific abstracts from IBD portfolio - TheFly
- 6 days ago - New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease - PRNewsWire
- 8 days ago - Looking for Dividend Aristocrats? These 3 Healthcare Stocks Deserve a Closer Look - TipRanks
- 9 days ago - AbbVie price target raised to $275 from $260 at UBS - TheFly
- 9 days ago - AbbVie price target raised to $305 from $289 at BofA - TheFly